These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 284720)

  • 1. Paracetamol (acetaminophen) clearance in patients with cirrhosis of the liver.
    Andreasen PB; Hutters L
    Acta Med Scand Suppl; 1979; 624():99-105. PubMed ID: 284720
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antipyrine, paracetamol, and lignocaine elimination in chronic liver disease.
    Forrest JA; Finlayson ND; Adjepon-Yamoah KK; Prescott LF
    Br Med J; 1977 May; 1(6073):1384-7. PubMed ID: 861646
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impaired elimination of caffeine in cirrhosis.
    Desmond PV; Patwardhan RV; Johnson RF; Schenker S
    Dig Dis Sci; 1980 Mar; 25(3):193-7. PubMed ID: 7371463
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Paracetamol metabolism in chronic liver disease.
    Forrest JA; Adriaenssens P; Finlayson ND; Prescott LF
    Eur J Clin Pharmacol; 1979 Jul; 15(6):427-31. PubMed ID: 499292
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Paracetamol (acetaminophen) kinetics in patients with Gilber's syndrome.
    Douglas AP; Savage RL; Rawlins MD
    Eur J Clin Pharmacol; 1978 May; 13(3):209-12. PubMed ID: 668775
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of diethyl ether anaesthesia on the pharmacokinetics of antipyrine and paracetamol in the rat.
    Johannessen W; Gadeholt G; Aarbakke J
    J Pharm Pharmacol; 1981 Jun; 33(6):365-8. PubMed ID: 6115008
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk prediction of hepatotoxicity in paracetamol poisoning.
    Wong A; Graudins A
    Clin Toxicol (Phila); 2017 Sep; 55(8):879-892. PubMed ID: 28447858
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics of diazepam in disordered liver function.
    Andreasen PB; Hendel J; Greisen G; Hvidberg EF
    Eur J Clin Pharmacol; 1976 Jun; 10(2):115-20. PubMed ID: 964287
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lack of effect of zinc supplementation on antipyrine clearance in alcoholic liver disease.
    Grønbaek K; Friis H; Feldman M; Sonne J; Andreasen PB
    Eur J Clin Pharmacol; 1996; 49(5):397-9. PubMed ID: 8866636
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antipyrine elimination in patients with alcoholic and non-alcoholic cirrhosis.
    Wensing G; Hoffmann K; Heidemann HT
    Z Gastroenterol; 1993 Jan; 31(1):15-9. PubMed ID: 8447150
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Colchicine clearance is impaired in alcoholic cirrhosis.
    Leighton JA; Bay MK; Maldonado AL; Schenker S; Speeg KV
    Hepatology; 1991 Dec; 14(6):1013-5. PubMed ID: 1959847
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics of antipyrine, warfarin and paracetamol in the brushtail possum.
    Eason CT; Wright GR; Gooneratne R
    J Appl Toxicol; 1999; 19(3):157-61. PubMed ID: 10362265
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics of paracetamol (acetaminophen) after intravenous and oral administration.
    Rawlins MD; Henderson DB; Hijab AR
    Eur J Clin Pharmacol; 1977 Apr; 11(4):283-6. PubMed ID: 862649
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thiopental pharmacokinetics in patients with cirrhosis.
    Pandele G; Chaux F; Salvadori C; Farinotti M; Duvaldestin P
    Anesthesiology; 1983 Aug; 59(2):123-6. PubMed ID: 6869869
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effects of hepatic and renal damage on paracetamol metabolism and excretion following overdosage. A pharmacokinetic study.
    Prescott LF; Wright N
    Br J Pharmacol; 1973 Dec; 49(4):602-13. PubMed ID: 4788034
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Determinants of serum antipyrine half-lives in patients with liver disease.
    Branch RA; Herbert CM; Read AE
    Gut; 1973 Jul; 14(7):569-73. PubMed ID: 4729926
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Abnormal drug metabolism after barbiturate and paracetamol overdose.
    Forrest JA; Roscoe P; Prescott LF; Stevenson IH
    Br Med J; 1974 Nov; 4(5943):499-502. PubMed ID: 4434117
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Elimination of paracetamol in chronic liver disease.
    Arnman R; Olsson R
    Acta Hepatogastroenterol (Stuttg); 1978 Aug; 25(4):283-6. PubMed ID: 696204
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relations between hepatotoxicity and pharmacokinetics of paracetamol in rats and mice.
    Siegers CP; Strubelt O; Schütt A
    Pharmacology; 1978; 16(5):273-8. PubMed ID: 643897
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antipyrine clearance and metabolite formation in patients with alcoholic cirrhosis.
    Teunissen MW; Spoelstra P; Koch CW; Weeda B; van Duyn W; Janssens AR; Breimer DD
    Br J Clin Pharmacol; 1984 Nov; 18(5):707-15. PubMed ID: 6508980
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.